Reply - 04/05/18
Doi : 10.1016/j.jaci.2017.11.016
A. Faiz Karim, MD a, b, ∗, Jorn J. Heeringa, MD a, ∗, Jan A.M. van Laar, MD, PhD a, b, Robert M. Verdijk, MD, PhD c, Willem A. Dik, PhD a, A. Dion Paridaens, MD, PhD d, P. Martin van Hagen, MD, PhD a, b, Menno C. van Zelm, PhD e 
a Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
b Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
c Department of Pathology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
d Department of Ophthalmology and the Department of Orbital Surgery, Rotterdam, The Netherlands
e Department of Immunology and Pathology, Central Clinical School, Monash University and Alfred Hospital, Melbourne, Victoria, Australia
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: J. J. Heeringa reports grants from Sophia Children's Hospital Fund during the conduct of the study. M. C. van Zelm reports grants from Sophia Children's Hospital Fund and grants from the NHMRC during the conduct of the study. In addition, he has patents EP 2780711 B1 and WO 2016068714 A2 issued. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2017
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1958 - mai 2018 Retour au numéro
Article précédent
- The call for considering follicular helper T cells in IgG4-related disease
- Mitsuhiro Akiyama
- Information for Readers
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?